International Stem Cell (ISCO) Asset Utilization Ratio (2016 - 2025)
International Stem Cell (ISCO) has disclosed Asset Utilization Ratio for 15 consecutive years, with 1.73 as the latest value for Q3 2025.
- On a quarterly basis, Asset Utilization Ratio rose 9.56% to 1.73 in Q3 2025 year-over-year; TTM through Sep 2025 was 1.73, a 9.56% increase, with the full-year FY2024 number at 1.72, up 16.22% from a year prior.
- Asset Utilization Ratio was 1.73 for Q3 2025 at International Stem Cell, up from 1.65 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.76 in Q4 2024 to a low of 1.11 in Q2 2021.
- A 5-year average of 1.48 and a median of 1.46 in 2024 define the central range for Asset Utilization Ratio.
- Peak YoY movement for Asset Utilization Ratio: decreased 20.2% in 2021, then grew 27.74% in 2022.
- International Stem Cell's Asset Utilization Ratio stood at 1.45 in 2021, then increased by 10.7% to 1.61 in 2022, then decreased by 12.15% to 1.41 in 2023, then increased by 24.28% to 1.76 in 2024, then decreased by 1.18% to 1.73 in 2025.
- Per Business Quant, the three most recent readings for ISCO's Asset Utilization Ratio are 1.73 (Q3 2025), 1.65 (Q2 2025), and 1.68 (Q1 2025).